Creating new treatments for neurological diseases by targeting RNA splicing
Developing Splicing-Targeted Therapeutic Strategies for Neurological Diseases
This study is looking at how changes in a specific process in our genes might affect brain cells and lead to neurological diseases, with the goal of finding new treatments to help people who are struggling with these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11080863 on NIH RePORTER |
What this research studies
This research focuses on understanding how alternative splicing of messenger RNA (mRNA) affects the development and function of neurons, which is crucial for brain health. By investigating the mechanisms behind splicing alterations, particularly in relation to the tau protein associated with neurological diseases, the researchers aim to develop targeted therapies that can correct these splicing errors. The study employs advanced techniques to identify genetic variants that influence splicing and their role in disease progression, potentially leading to innovative treatment options for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with neurodevelopmental or neurodegenerative diseases associated with tau protein abnormalities.
Not a fit: Patients with neurological conditions unrelated to RNA splicing or tau protein may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve outcomes for patients with neurological diseases linked to splicing abnormalities.
How similar studies have performed: Previous research has shown promising results in targeting RNA splicing for therapeutic purposes, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Morini, Elisabetta — Massachusetts General Hospital
- Study coordinator: Morini, Elisabetta
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.